Publication | Open Access

Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma

Neuro-oncologyTemozolomide ChemotherapyImmunotherapyGlioma CellsMedicineImmunologyImmune Checkpoint InhibitorHigh-grade GliomasPhase I/ii TrialCancer TreatmentRadiation OncologyOncologyGlioma